Press releases | WebDisclosure

Basculer en Français

11293	Companies
250965	Keywords
179876	Articles
136835	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 09/26/2025 at 07:30, 1 year 1 month ago

Gimv en EGS Beteiligungen versterken hun strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF ter versnelling van wereldwijde groei
Gimv en EGSB versterken strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF voor wereldwijde groei in wervelkolomchirurgie

Gimv Kapitaalverhoging Spineart EGSB Wervelkolomchirurgie
REGULATED PRESS RELEASE

published on 09/26/2025 at 07:30, 1 year 1 month ago

Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth
Gimv and EGS Beteiligungen invest CHF 25 million in Spineart to boost global growth in advanced spine surgery solutions

Gimv Global Growth EGS Beteiligungen Spineart CHF 25 Million
PRESS RELEASE

published on 09/26/2025 at 07:30, 1 year 1 month ago

Informations privilégiées / Autres communiqués
Hoffmann Green annonce le vif succès de son augmentation de capital d'environ 7,9 M€ pour accélérer son développement commercial et industriel

Augmentation De Capital Décarbonation Développement Commercial Succès Hoffmann Green
PRESS RELEASE

published on 09/26/2025 at 07:30, 1 year 1 month ago

Inside Information / Other news releases
Hoffmann Green Cement announces successful €7.9 million capital increase for commercial and industrial growth. New shares issued at €4.50 unit price. Settlement on September 30, 2025

Capital Increase New Shares Commercial Development Hoffmann Green Cement Industrial Growth
PRESS RELEASE

published on 09/26/2025 at 07:00, 1 year 1 month ago

OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture

Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
PRESS RELEASE

published on 09/26/2025 at 07:00, 1 year 1 month ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
PRESS RELEASE

published on 09/26/2025 at 06:30, 1 year 1 month ago

Change in the Chairmanship of the Board of Directors
Change in the Chairmanship of the Board of Directors at Siegfried AG as Dr. Andreas Casutt steps down, proposing Dr. Beat Walti as the new Chairman. Siegfried Holding AG continues its successful growth journey

Board Of Directors Chairmanship Siegfried AG Dr. Andreas Casutt Dr. Beat Walti
PRESS RELEASE

published on 09/26/2025 at 06:12, 1 year 1 month ago

Ad hoc-annoucement pursuant to Art. 53 LR
Adval Tech Management AG releases ad hoc announcement pursuant to Art. 53 LR. For more information, visit www.advaltech.com

Ad Hoc Announcement SIX Swiss Exchange EQS News Adval Tech Management AG Art. 53 LR
PRESS RELEASE

published on 09/26/2025 at 05:15, 1 year 1 month ago

NioCorp Announces Commencement of Proposed Public Offering of Common Shares
NioCorp commences public offering in the United States via Maxim Group LLC for its Elk Creek Project, aiming to raise capital for construction and operations

Elk Creek Project NioCorp Maxim Group LLC Public Offering Capital Raising
PRESS RELEASE

published on 09/26/2025 at 02:01, 1 year 1 month ago

Wellgistics Health Announces Pricing of $5 Million Public Offering
Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co

Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX

Accesswire

Published on 11/06/2026 at 22:15, 14 hours 9 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 23 hours 24 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 23 hours 54 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 23 hours 54 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 2 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 20:15, 16 hours 9 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 16 hours 9 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 17 hours 9 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 17 hours 24 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 17 hours 52 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

Les Echos

Published on 11/06/2026 at 19:06, 17 hours 18 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 17 hours 20 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 17 hours 22 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 17 hours 24 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 18 hours 24 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE